http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101146597-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6857 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0066 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2010-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101146597-B1 |
titleOfInvention | Composition for diagnosing vitiligo |
abstract | From the group consisting of aquaporin 3, E-cadherin, β-catenin, γ-catenin, PI3K, AKT, inositol 1,4,5-triphosphate 3-kinase C, keratin 10, and keratin 1 Provided are a composition for diagnosing vitiligo and a gene therapy composition for the prevention and treatment of vitiligo, comprising a sequence encoding aquaporin 3, characterized by a decrease in selected depigmented vitiligo skin. |
priorityDate | 2010-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 978.